It has been reported that the components of the upstream and downstream signaling of mTOR pathway are often changed to promote tumor progression in various types of cancers, such as amplification of PI3K, loss of PTEN function and overexpression of AKT [70]. The gene discussed is MTOR; the disease is cancer.